Count | |
6 | |
34 | |
1 | |
2 | |
1 | |
1 | |
1 | |
1 | |
1 | |
1 | |
Muscarinic Agonists/administration & dosage/*therapeutic use | 1 |
5 | |
15 | |
1 | |
1 | |
Muscarinic Antagonists/administration & dosage/*pharmacology | 1 |
2 | |
Muscarinic Antagonists/*chemical synthesis/chemistry/pharmacology | 1 |
1 | |
1 | |
7 | |
18 | |
1 | |
1 | |
8 | |
2 | |
12 | |
1 | |
1 | |
24 | |
7 | |
1 | |
2 | |
5 | |
1 | |
3 | |
1 | |
1 | |
3 | |
1 | |
7 | |
1 | |
10 | |
1 | |
1 | |
2 | |
1 | |
1 | |
1 | |
3 | |
13 | |
49 | |
1 | |
21 | |
1 | |
1 | |
12 | |
24 | |
1 | |
1 | |
1 | |
22 | |
1 | |
8 | |
1 | |
1 | |
1 | |
1 | |
16 | |
1 | |
1 | |
1 | |
Oligoribonucleotides/agonists/chemical synthesis/*pharmacology | 1 |
1 | |
1 | |
1 | |
1 | |
1 | |
1 | |
1 | |
1 | |
Lipopolysaccharides/*agonists/*antagonists & inhibitors/*pharmacology | 1 |
1 | |
2 | |
1 | |
1 | |
1 | |
24 | |
15 | |
1 | |
3 | |
17 | |
2 | |
3 | |
Dopamine Agonists/administration & dosage/pharmacology/*therapeutic use | 1 |
1 | |
Adrenergic beta-Agonists/administration & dosage/pharmacology | 1 |
1 | |
Cytokines/agonists/antagonists & inhibitors/metabolism/pharmacology | 1 |
Serotonin Agonists/administration & dosage/*pharmacokinetics/pharmacology | 1 |